Showing results (41-50 of 113) with videos related to
Sort By:
Pageof 12
Journal of Clinical Medicine|May 28, 2022
Impact of On-Clopidogrel Platelet Reactivity on Incidence of Peri-Interventional Bleeding in Patients Undergoing Transcatheter Aortic Valve ImplantationAlexander Kille, Kilian Franke, Noé Corpataux, et al.European Heart Journal. Cardiovascular Pharmacotherapy|April 4, 2023
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes-a substudy of the TROPICAL-ACS trialAndrás Komócsi, Béla Merkely, Martin Hadamitzky, et al.The American Journal of Cardiology|July 8, 2008
Percutaneous coronary intervention versus coronary artery bypass grafting as primary revascularization in patients with acute coronary syndromeWillibald Hochholzer, Heinz Joachim Buettner, Dietmar Trenk, et al.Journal of the American College of Cardiology|July 16, 2016
Comparison of Immature Platelet Count to Established Predictors of Platelet Reactivity During Thienopyridine TherapyChristian Stratz, Timo Bömicke, Iris Younas, et al.Thrombosis and Haemostasis|January 20, 2017
Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE)Uwe Zeymer, Thomas Hohlfeld, Jürgen Vom Dahl, et al.Journal of Cardiovascular Translational Research|November 29, 2012
Transcriptome analysis in patients with progressive coronary artery disease: identification of differential gene expression in peripheral bloodThomas G Nührenberg, Nicole Langwieser, Harald Binder, et al.Journal of the American College of Cardiology|April 24, 2012
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) studyDietmar Trenk, Gregg W Stone, Meinrad Gawaz, et al.European Journal of Heart Failure|May 27, 2019
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trialMartin Schulz, Nina Griese-Mammen, Stefan D Anker, et al.The American Journal of Medicine|December 25, 2016
Prognostic Value of High-Sensitivity Cardiac Troponin T Compared with Risk Scores in Stable Cardiovascular DiseaseMoritz Biener, Evangelos Giannitsis, Manuel Kuhner, et al.Journal of the American College of Cardiology|December 17, 2013
Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2)Dominick J Angiolillo, Nicholas Curzen, Paul Gurbel, et al.Pageof 12